Skip to content
Open access · CC-BY via OpenAlex

Okadaic acid: a tool to study regulatory mechanisms for neurodegeneration and regeneration in Alzheimer′s disease

Pradip Kumar Kamat, Chandishwar Nath

Neural Regeneration Research · 2015 · ▲ 42 citations

Abstract

Okadaic acid: Okadaic acid (OKA), a polyether (C38 fatty acid) toxin, is a potent and selective inhibitor of protein phosphatase, PP1 and protein phosphatase 2A (PP2A). It is mainly extracted from a black sponge Hallichondria okadaii and has been suggested to play a potent probe for studying the various molecular, cellular, biochemical and mechanism of neurotoxicity. It is known as a selective and potent inhibitor of serine/threonine phosphatases 1 and 2A induces hyperphosphorylation of tau in vitro and in vivo. It has been reported that Alzheimer's disease (AD) is a complex multifactorial neurodegenerative disorder and hyperphosphorylated tau protein is a major pathological hallmark of AD. The reduced activity of phosphatases like, PP2A has been implicated in the brain of AD patients. OKA also induced inhibition of protein phosphatases cause neurofibrillary tangles (NFTs) like pathological changes and tau hyperphosphorylation seen in AD pathology. Our and others reports inferred that OKA induces neurodegeneration along with tau hyperphosphorylation, GSK3β activation, oxidative stress, neuroinflammation and neurotoxicity which are characteristic of AD pathology (Figure 1).Figure 1: Cartoon represents the effects of okadaic acid (OKA) on various biochemical and molecular events such as tau hyperphosphorylation, apoptosis, synapse dysfunction, cholinergic dysfunction, free radical injury and neuroinflammation which are contributory factors in AD pathogenesis.AD: Alzheimer's disease; NMDA: N-methyl-D-aspartate.Alzheimer's disease (AD): AD is pathologically characterized by deposition of extracellular amyloid beta (Aβ) plaques and intracellular NFTs (Najem et al., 2014). NFTs are composed of bundles of paired helical filaments (PHFs) and conservative filaments which are the major protein components of the abnormally hyperphosphorylated tau protein. Tau is a major phosphoprotein in central nervous system which usually containing two to three phosphate groups per molecule. Abnormal hyperphosphorylation of tau is believed to be responsible for neuronal toxicity and loss of neuronal activity which further promotes aggregation of PHFs (Murray et al., 2013). Hence, the abnormal hyperphosphorylation of tau appears to be critical to the pathogenesis of AD. Tau phosphorylation is usually catalyzed by tau protein kinases and reversed by tau protein phosphatases (PPs). There are many phosphatases expressed in brain and among them PP2A is highly expressed. OKA has potential properties to inhibit PP2A activity thereby causing tau hyperphosphorylation. It has been reported that the expressions and activities of some phosphatases are decreased in the affected areas of AD brain. Our observations from several studies suggest that a down regulation of tau phosphatases in AD brain might trigger the abnormal hyperphosphorylation of tau and other neuronal proteins. Interestingly, OKA showed similar kind of properties in various studies. Okadaic acid and kinases: Recent studies have also emphasized the importance of serine/threonine protein phosphatases in many neurodegenerative processes including neuronal apoptosis. The serine/threonine protein phosphatases are also associated with activation of major kinases such as Ser/Thr, MAPK, ERK, PKA, JNK, PKC and GSK3β in neurons. These enzymes and signaling molecules are actively associated with AD pathology. These kinases promote abnormal hyperphosphorylation of tau, suggest that the cascade of these kinases could exclusively be involved in the pathogenesis of AD. The activity of serine/threonine protein phosphatases needs extensive study and OKA is a very important and suggestive tool for this purpose. These enzymes are potential targets for many diseases, including inflammatory and neurodegenerative diseases. Reports from a previous study suggested that OKA may have rapid metabolic consequences on cell death by altering rates of phosphorylation-dephosphorylation in vivo. OKA leads to β-amyloid deposition and subsequent neuronal degeneration, synaptic loss, and memory impairments, all of these are characteristic features of AD progression (Kamat, 2013, 2014). Cognitive deficiency/dementia or cognitive functional declines are the ultimate outcomes in AD patients. Our lab reports have shown that the microinfusion/intracebroventricular/intracerebral injection of OKA into the rodent's brain causes cognitive deficiency by β-amyloid deposition and tau hyperphosphorylation. The phosphorylation state of proteins modulated by protein kinases and protein phosphatases is important in the regulation of physiological processes. In the central nervous system, protein phosphorylation plays a critical role in the molecular mechanisms through which neurotransmitters and hormones produce their biological effects in target cells (Duan et al., 2013). Alteration of the normal rates of phosphorylation and dephosphorylation of proteins may affect neuronal functions. There are some evidences which support that protein kinases and phosphatases are involved in the cascade of events that contribute to neuronal toxicity under pathological conditions (Crespo-Biel et al., 2013). The neurotoxicity which is associated with an abnormally phosphorylated form of the microtubule-associated protein (MAP) tau promotes AD-like pathology. Tau protein is a major constituent of the paired helical filaments, characteristic of the AD and their aberrant protein phosphorylation has also been implicated in the processing and secretion of amyloid peptides whose extracellular deposition forms the senile plaques (Tamaoka et al., 2013). In clinical set of experiment; it has been observed that, in AD brain, the activity of PP2A appears to be reduced in both gray and white matters and a down-regulation of this enzyme is apparently involved in slowing down the process of tau dephosphorylation. Several studies have suggested the significance of MAPK cascade in mammalian synaptic plasticity, learning, and memory (Sharma e

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.4103/1673-5374.153679
Canonical
link ↗
Fetched
2026-11-06 MST

Cite this

APA
Kamat, P.K., &amp; Nath, C. (2015). Okadaic acid: a tool to study regulatory mechanisms for neurodegeneration and regeneration in Alzheimer′s disease. <em>Neural Regeneration Research</em>. https://doi.org/10.4103/1673-5374.153679
Vancouver
Kamat PK, Nath C. Okadaic acid: a tool to study regulatory mechanisms for neurodegeneration and regeneration in Alzheimer′s disease. Neural Regeneration Research. 2015. doi:10.4103/1673-5374.153679.
BibTeX
@article{pradip2015Okadai, title = {Okadaic acid: a tool to study regulatory mechanisms for neurodegeneration and regeneration in Alzheimer′s disease}, author = {Pradip Kumar Kamat and Chandishwar Nath}, journal = {Neural Regeneration Research}, year = {2015}, doi = {10.4103/1673-5374.153679}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings